Share
Journal Information
Special content about coronavirus SARS-CoV-2 (COVID-19) in Annals of Hepatology
Type 2 diabetes mellitus in metabolic-associated fatty liver disease vs. type 2 diabetes mellitus non-alcoholic fatty liver disease: a longitudinal cohort analysis
Mark Muthiah, Cheng Han Ng, Kai En Chan, Clarissa Elysia Fu, Wen Hui Lim, Darren Jun Hao Tan, Benjamin Nah, Gwyneth Kong, Jieling Xiao, Jie Ning Yong, Bryan Tan, Nicholas Syn, Jiong-Wei Wang, Nilofer Sayed, Eunice Tan, Nicholas WS Chew, Yock Young Dan, Mohammad Shadab Siddiqui, Arun J. Sanyal, Mazen Noureddin
10.1016/j.aohep.2022.100762
Ann Hepatol. 2023;28:
Open access
Effects of in vitro lipid overload on LX-2 hepatic stellate cells
A Campos-Espinosa, G Gutiérrez-Reyes, C Guzmán
10.1016/j.aohep.2022.100858
Ann Hepatol. 2022;27 Supl 3:
Open access
Serum determination of MMP-2 and MMP-9 in chronic liver disease according to alcohol consumption, non-alcoholic fatty liver disease and hepatitis C
M Lemus-Peña, D Montes de Oca-Ángeles, M Hernandez-Santillan, A Hernandez-Barragan, D Santana-Vargas, M Martinez-Castillo, Z Medina-Avila, A Torre-Delgadillo, JL Pérez-Hernández, F Higuera-De la Tijera, P Cordero-Pérez, L Muñoz-Espinosa, D Kershenobich, G Gutiérrez-Reyes
10.1016/j.aohep.2022.100868
Ann Hepatol. 2022;27 Supl 3:
Open access
Changes in physical activity and its impact on MAFLD during the COVID-19 pandemic
MJJ García-Carvajal, AD Cano-Contreras, MR Francisco, HR Ordaz-Álvarez, SA Reyes-Díaz, M Vieyra-Vega, JC Ortiz-Zarate, JM Remes-Troche
10.1016/j.aohep.2022.100834
Ann Hepatol. 2022;27 Supl 3:
Open access
Manifestations of SARS-COV-2 in patients with chronic liver disease
AE Jiménez-Partida, MA Jiménez-Luévano, MA Jiménez-Partida, A Bravo-Cuellar, Y Cortes-Aguilar
10.1016/j.aohep.2022.100837
Ann Hepatol. 2022;27 Supl 3:
Open access
Pilot study: management with pentoxifylline in patients with chronic liver disease and COVID-19
MA Jiménez-Luévano, AE Jiménez-Partida, MA Jiménez-Partida, A Bravo-Cuellar, Y Cortes-Aguilar
10.1016/j.aohep.2022.100838
Ann Hepatol. 2022;27 Supl 3:
Open access
Diethylnitrosamine and 2-acetylaminofluorene chronic administration leads to biochemical and histologic changes related to hepatocellular carcinoma in Wistar rats
J Sánchez-Meza, M Campos-Valdez, JA Domínguez-Rosales, SC Rodríguez-Reyes, E Martínez-López, JM Godínez-Rubí, LV Sánchez-Orozco
10.1016/j.aohep.2022.100851
Ann Hepatol. 2022;27 Supl 3:
Open access
The possibility of hepatitis C reactivation in COVID-19 patients treated with corticosteroids
Somayeh Shokri, Shahab Mahmoudvand
10.1016/j.aohep.2022.100704
Ann Hepatol. 2022;27:
Open access
Trends in drug prescriptions for type 2 diabetes, hypertension, and dyslipidemia among adults with non-alcoholic fatty liver disease
Toshiya Machida, Taku Obara, Makoto Miyazaki, Jun Inoue, Nariyasu Mano
10.1016/j.aohep.2022.100699
Ann Hepatol. 2022;27:
Open access
Antibody response after a booster dose of SARS-CoV-2 vaccine in liver transplant recipients and those with chronic liver diseases
Mahak Chauhan, Ihechiluru Nzeako, Feng Li, Paul J. Thuluvath
10.1016/j.aohep.2022.100702
Ann Hepatol. 2022;27:
Open access
Publish in
Annals of Hepatology
Affiliated societies
